Who owns Signadori Bio?

Signadori Bio is currently owned by Sofinnova Partners, through Sofinnova Biovelocita II, since 2025.

When did Sofinnova Partners acquire Signadori Bio?

Sofinnova Partners acquired Signadori Bio in 2025 (active for 1 year).

Biotech·

Italy·Active·1yr hold

Signadori Bio is a healthcare / biotech company, headquartered in Italy.

Entry

2025

Hold

1yr

Status

Active

Est. EV

–

Investor

HQItaly

SectorHealthcare / Biotech

Italian preclinical biotech developing innovative cell therapy approaches to treat cancer, based on technology from Institut Gustave Roussy.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Already a member? Sign in

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings